Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 249

1.

Preoperative neutrophil-lymphocyte ratio as an independent prognostic marker for patients with upper urinary tract urothelial carcinoma.

Azuma T, Matayoshi Y, Odani K, Sato Y, Sato Y, Nagase Y, Oshi M.

Clin Genitourin Cancer. 2013 Sep;11(3):337-41. doi: 10.1016/j.clgc.2013.04.003. Epub 2013 May 9.

PMID:
23665132
2.

Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.

Dalpiaz O, Ehrlich GC, Mannweiler S, Hernández JM, Gerger A, Stojakovic T, Pummer K, Zigeuner R, Pichler M, Hutterer GC.

BJU Int. 2014 Sep;114(3):334-9. doi: 10.1111/bju.12441. Epub 2013 Nov 27.

3.
4.

Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.

Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V.

Eur Urol. 2012 Apr;61(4):818-25. doi: 10.1016/j.eururo.2012.01.021. Epub 2012 Jan 23.

PMID:
22284969
5.

Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.

Hermanns T, Bhindi B, Wei Y, Yu J, Noon AP, Richard PO, Bhatt JR, Almatar A, Jewett MA, Fleshner NE, Zlotta AR, Templeton AJ, Kulkarni GS.

Br J Cancer. 2014 Jul 29;111(3):444-51. doi: 10.1038/bjc.2014.305. Epub 2014 Jun 10.

6.

A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.

Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Shirotake S, Miyazaki Y, Kobayashi H, Kaneko G, Hagiwara M, Ide H, Obata J, Hoshino K, Hayakawa N, Kosaka T, Hara S, Oyama M, Momma T, Nakajima Y, Jinzaki M, Oya M.

Ann Surg Oncol. 2014 Nov;21(12):4041-8. doi: 10.1245/s10434-014-3830-3. Epub 2014 Jun 10.

PMID:
24912614
7.

Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.

Vartolomei MD, Mathieu R, Margulis V, Karam JA, Rouprêt M, Lucca I, Mbeutcha A, Seitz C, Karakiewicz PI, Fajkovic H, Wood CG, Weizer AZ, Raman JD, Rioux-Leclercq N, Haitel A, Bensalah K, Rink M, Briganti A, Xylinas E, Shariat SF.

World J Urol. 2017 Jan;35(1):121-130. doi: 10.1007/s00345-016-1848-9. Epub 2016 May 21.

8.

Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.

Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.

J Urol. 2007 Dec;178(6):2291-6; discussion 2296. Epub 2007 Oct 22.

PMID:
17936818
9.

Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.

Viers BR, Boorjian SA, Frank I, Tarrell RF, Thapa P, Karnes RJ, Thompson RH, Tollefson MK.

Eur Urol. 2014 Dec;66(6):1157-64. doi: 10.1016/j.eururo.2014.02.042. Epub 2014 Feb 26.

PMID:
24630414
10.

A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation.

Wang GY, Yang Y, Li H, Zhang J, Jiang N, Li MR, Zhu HB, Zhang Q, Chen GH.

PLoS One. 2011;6(9):e25295. doi: 10.1371/journal.pone.0025295. Epub 2011 Sep 26.

11.

Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.

Kuroda K, Asakuma J, Horiguchi A, Tasaki S, Yoshii H, Sato A, Ito K, Seguchi K, Sumitomo M, Asano T.

Urol Int. 2012;88(2):225-31. doi: 10.1159/000335274. Epub 2012 Jan 11.

PMID:
22236640
12.

Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.

Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W.

BJU Int. 2012 Jul;110(2 Pt 2):E7-13. doi: 10.1111/j.1464-410X.2011.10792.x. Epub 2011 Dec 16.

13.

Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.

Gondo T, Nakashima J, Ohno Y, Choichiro O, Horiguchi Y, Namiki K, Yoshioka K, Ohori M, Hatano T, Tachibana M.

Urology. 2012 May;79(5):1085-91. doi: 10.1016/j.urology.2011.11.070. Epub 2012 Mar 23.

PMID:
22446338
14.

Preoperative serum sodium is associated with cancer-specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy.

Fujita K, Tanigawa G, Imamura R, Nakagawa M, Hayashi T, Kishimoto N, Hosomi M, Yamaguchi S.

Int J Urol. 2013 Jun;20(6):594-601. doi: 10.1111/j.1442-2042.2012.03228.x. Epub 2012 Nov 7.

15.

Preoperative prognostic factors after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Morizane S, Iwamoto H, Masago T, Yao A, Isoyama T, Sejima T, Takenaka A.

Int Urol Nephrol. 2013 Feb;45(1):99-106. doi: 10.1007/s11255-012-0347-1. Epub 2012 Dec 11.

PMID:
23229166
16.

The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically.

Saito K, Kawakami S, Ohtsuka Y, Fujii Y, Masuda H, Kumagai J, Kobayashi T, Kageyama Y, Kihara K.

BJU Int. 2007 Aug;100(2):269-73. Epub 2007 May 4.

17.

Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer.

Absenger G, Szkandera J, Stotz M, Postlmayr U, Pichler M, Ress AL, Schaberl-Moser R, Loibner H, Samonigg H, Gerger A.

Anticancer Res. 2013 Oct;33(10):4591-4.

PMID:
24123035
18.

Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival.

Colin P, Ouzzane A, Yates DR, Audenet F, Pignot G, Arvin-Berod A, Merigot de Treigny O, Laurent G, Valeri A, Irani J, Saint F, Gardic S, Gres P, Rozet F, Neuzillet Y, Ruffion A, Rouprêt M.

Ann Surg Oncol. 2012 Oct;19(11):3613-20. doi: 10.1245/s10434-012-2453-9. Epub 2012 Jul 28. Erratum in: Ann Surg Oncol. 2013 Dec;20 Suppl 3:S750. François, Audenet [corrected to Audenet, François]; Jacques, Irani [corrected to Irani, Jacques].

PMID:
22843187
19.

Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.

Sun J, Ning H, Sun J, Qu X.

Urol Oncol. 2016 May;34(5):239.e9-15. doi: 10.1016/j.urolonc.2015.12.006. Epub 2016 Jan 21.

PMID:
26803433
20.

NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder.

Potretzke A, Hillman L, Wong K, Shi F, Brower R, Mai S, Cetnar JP, Abel EJ, Downs TM.

Urol Oncol. 2014 Jul;32(5):631-6. doi: 10.1016/j.urolonc.2013.12.009. Epub 2014 Mar 12.

PMID:
24629498

Supplemental Content

Support Center